Snow Leopard
Hibernating
- Messages
- 5,902
- Location
- South Australia
This has probably been posted before, but I just noticed it...
I wish I could swim... or dance.
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
This has probably been posted before, but I just noticed it...
I prefer to think big.I wish I could swim... or dance.
Another view of course is that most didn't necessarily dance, cycle and swim. We are not given data that they did actually do these things. We saw in the PACE Trial no improvement in the fitness test which would be an odd result if people were exercising regularly. Similarly final scores at end of PACE Trial for 6-minute walking test still very poor and not what one would expect if most people were regularly dancing, cycling and swimming.@Dolphin pointed out that all of the studies in the review recruited using Oxford or Fukuda/CDC, so post exertional malaise wasn't a required feature in the patients they studied. They studied chronic fatigue. (That explains how the patients could dance, cycle and swim!)
If I could swim, cycle and/or dance, I'm not sure that I'd need exercise therapy for my 'fatigue'! So, what's the point of these studies'? What am I missing?
Ah, I haven't read the full paper, but my assumption from the wording was that some patients could dance/swim/cycle from the beginning of the studies; It didn't occur to me that the treatments may have enabled participants to dance/swim/cycle. So I may have misinterpreted. My earlier comments should be viewed from the point of view of the participants being able to dance/swim/cycle at the beginning of the studies. If I misinterpreted the text then my comments aren't helpful.Another view of course is that most didn't necessarily dance, cycle and swim. We are not given data that they did actually do these things. We saw in the PACE Trial no improvement in the fitness test which would be an odd result if people were exercising regularly. Similarly final scores at end of PACE Trial for 6-minute walking test still very poor and not what one would expect if most people were regularly dancing, cycling and swimming.
But it is frustrating that should loose definitions are used. Perhaps small numbers of people do get quite active and this can convince professionals that everyone else could do it.
Anyway, you make some interesting points but I just wanted to pick up on that point.
Ok. No, the reference to dancing* is simply from the list of options some patients were given as a way to exercise inAh, I haven't read the full paper, but my assumption from the wording was that some patients could dance/swim/cycle from the beginning of the studies; It didn't occur to me that the treatments may have enabled participants to dance/swim/cycle. So I may have misinterpreted. My earlier comments should be viewed from the point of view of the participants being able to dance/swim/cycle at the beginning of the studies. If I misinterpreted the text then my comments aren't helpful.
so one wonders how many actually did dancing, swimming and cycling.
Yes. But perhaps because of the way it is presented, readers might think they were actually done in one or more trials as Bob assumed. For example, this is from the abstract:Since there is no data to show that such activities did actually occur, it could be considered merely a suggestion.
Seven studies used variations of aerobic exercise therapy such as walking, swimming, cycling or dancing provided at mixed levels in terms of intensity of the aerobic exercise from very low to quite rigorous, whilst one study used anaerobic exercise.
Marques M, De Gucht V, Maes S, Leal I. Protocol for the “four steps to control your fatigue (4-STEPS)” randomised controlled trial: a self-regulation based physical activity intervention for patients with unexplained chronic fatigue. BMC Public Health 2012;12:202. [DOI: 10.1186/ 1471-2458-12-202]
I wish I could swim... or dance.
Thanks for the info.Ok. No, the reference to dance/swim/cycle is simply from the list of options some patients were given as a way to exercise insome studiesjust one study (FINE Trial). The FINE Trial started off as being on the severely affected although I think all weren't. But the average baseline SF-36 PF score was 29.84 and they finished at 43.27 so one wonders how many actually did dancing, swimming and cycling.
Don't know. But doubt it is Michael Maes based on what he has written.Marques M, De Gucht V, Maes S, Leal I. Protocol for the “four steps to control your fatigue (4-STEPS)” randomised controlled trial: a self-regulation based physical activity intervention for patients with unexplained chronic fatigue. BMC Public Health 2012;12:202. [DOI: 10.1186/ 1471-2458-12-202]
Is Maes a common name? Not heard of S Maes before. I see that one is on 'unexplained chronic fatigue'.
MeSci said:Is Maes a common name? Not heard of S Maes before. I see that one is on 'unexplained chronic fatigue'.
It's Stan Maes, Professor Clinical and Health Psychology at Leiden University in the Netherlands. He seems to focus on (self-)management of chronic illnesses (like heart disease, RA or CFS). List of published work here.Don't know. But doubt it is Michael Maes based on what he has written.
Just thought I'd bump this up.Looks like responses can be sent and should be replied to:
http://editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/14532_Final Print Ready.pdf
Edit. Not exactly clear where they should be sent. Anxiety, Neurosis and Depression Group?
Looks like this is it:
Cochrane Depression, Anxiety and Neurosis Group
Contact us
CCDAN Editorial Base Office
+44 (0)117 331 0172
contact@ccdan.org
Centre for Academic Mental Health, University of Bristol
Oakfield House, Oakfield Grove
Bristol, BS8 2BN
United Kingdom
Co-ordinating Editor: Dr Rachel Churchill
Managing Editor: Jessica Sharp
Trials Search Co-ordinator: Sarah Dawson
For what it's worth (some might not agree with about the PACE Trial for example but they don't cover the recovery criteria which is where the biggest problem was I think it's fair to say):
Selective reporting
Two studies (Wearden 2010; White 2011) referenced published protocols, and when we checked these against the published results, we found that reporting was adequate. In one study (Wearden 1998), trial investigators reported numerical data for only one subscale (health perception) of the Medical Outcomes Survey (MOS) scale (Ware 1992), for which data favour the intervention group; no numerical data were given for the five other subscales, nor for another scale (anxiety), as data were “similar in trial completers.” It was not possible to check the other studies for selective reporting bias; therefore their risk of bias is considered unclear.
SELECTIVE REPORTING
Reporting bias due to selective outcome reporting.
Criteria for a judgement of ‘Low risk’ of bias.
Any of the following:
- The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way;
- The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).
Criteria for the judgement of ‘High risk’ of bias.
Any one of the following:
- Not all of the study’s pre-specified primary outcomes have been reported;
- One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified;
- One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect);
- One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis;
- The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Criteria for the judgement of ‘Unclear risk’ of bias.
Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’. It is likely that the majority of studies will fall into this category.
Primary outcome measures – Primary efficacy measures
Since we are interested in changes in both symptoms and disability we have chosen to designate both the symptoms of fatigue and physical function as primary outcomes. This is because it is possible that a specific treatment may relieve symptoms without reducing disability, or vice versa. Both these measures will be self-rated.
The 11 item Chalder Fatigue Questionnaire measures the severity of symptomatic fatigue 27], and has been the most frequently used measure of fatigue in most previous trials of these interventions. We will use the 0,0,1,1 item scores to allow a possible score of between 0 and 11. A positive outcome will be a 50% reduction in fatigue score, or a score of 3 or less, this threshold having been previously shown to indicate normal fatigue 27].
The SF-36 physical function sub-scale 29] measures physical function, and has often been used as a primary outcome measure in trials of CBT and GET. We will count a score of 75 (out of a maximum of 100) or more, or a 50% increase from baseline in SF-36 sub-scale score as a positive outcome. A score of 70 is about one standard deviation below the mean score (about 85, depending on the study) for the UK adult population 51,52].
Those participants who improve in both primary outcome measures will be regarded as overall improvers.
Adverse outcomes
Adverse outcomes (score of 5–7 of the self-rated CGI) will be monitored by examining the CGI at all follow-up assessment interviews 49]. An adverse outcome will be considered to have occurred if the physical function score of the SF-36 28] has dropped by 20 points from the previous measurement. This deterioration score has been chosen since it represents approximately one standard deviation from the mean baseline scores (between 18 and 27) from previous trials using this measure 23,25]. Furthermore, the RN will enquire regarding specific adverse events at all follow-up assessment interviews.